Protara Therapeutics (TARA) Notes Payables (2013 - 2020)
Protara Therapeutics (TARA) posted quarterly Notes Payables of $370793.0 for Q3 2020, down 60.0% quarter-over-quarter from $926983.0 in Q2 2020.
Powered by 
Analysis
Protara Therapeutics (TARA) Notes Payables (2013 - 2020) Analysis & Trends
Protara Therapeutics (TARA) has reported Notes Payables for 2 consecutive years, with $370793.0 the latest figure, recorded in Q3 2020.
- In Q3 2020, Notes Payables changed N/A year-over-year to $370793.0; the TTM figure through Sep 2020 stood at $370793.0 (changed N/A YoY), while the FY2013 annual figure was $1.4 million, changed N/A from the prior year.
- Notes Payables retreated to $370793.0 in Q3 2020 per TARA's latest filing, from $926983.0 in the prior quarter.
- Across five years, Notes Payables topped out at $1.3 million in Q1 2020 and bottomed at $370793.0 in Q3 2020.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Protara Therapeutics | 241.28 Mn | 241.28 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2020 | 370,793.00 |
| Jun 30, 2020 | 926,983.00 |
| Mar 31, 2020 | 1.30 Mn |
| Dec 31, 2013 | 3.73 Mn |